NurExone Biologic Inc. is a publicly-traded biopharmaceutical company, listed on the Toronto Stock Exchange (TSXV: NRX), the OTCQB Venture Market (OTCQB:NRXBF) and Frankfurt Stock Exchange (TSXV: NRX). Developing and commercializing the ExoTherapy platform for production of exosome-loaded nanodrugs.

Content Locked
Login or Register a FREE account to continue browsing our content
2020
Haifa, Israel

-
Post-IPO Equity| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content